Real-time enrollment status for this antineutrophilic cytoplasmic antibody (anca)- associated vasculitis (aav) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:50 AM UTC
| NCT Number | NCT06308978 |
| Recruiting Status | Recruiting |
| Condition | Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV) |
| Phase | Clinical Trial |
| Target Enrollment | 244 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Fate Therapeutics |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 13, 2026: Clinical trial NCT06308978 is currently recruiting participants. This clinical trial study for antineutrophilic cytoplasmic antibody (anca)- associated vasculitis (aav) is actively seeking new participants at 16 locations across the United States. The study is sponsored by Fate Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06308978 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06308978 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.